Syndax Pharmaceuticals Inc (SNDX)
19.89
-0.22
(-1.09%)
USD |
NASDAQ |
Jun 17, 16:00
19.89
0.00 (0.00%)
After-Hours: 20:00
Syndax Pharmaceuticals Total Liabilities (Quarterly): 51.14M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 51.14M |
| December 31, 2023 | 58.68M |
| September 30, 2023 | 40.04M |
| June 30, 2023 | 31.30M |
| March 31, 2023 | 24.32M |
| December 31, 2022 | 29.79M |
| September 30, 2022 | 21.58M |
| June 30, 2022 | 44.50M |
| March 31, 2022 | 47.67M |
| December 31, 2021 | 41.29M |
| September 30, 2021 | 40.50M |
| June 30, 2021 | 48.50M |
| March 31, 2021 | 51.47M |
| December 31, 2020 | 48.42M |
| September 30, 2020 | 47.33M |
| June 30, 2020 | 44.98M |
| March 31, 2020 | 51.65M |
| December 31, 2019 | 31.92M |
| September 30, 2019 | 32.34M |
| June 30, 2019 | 32.12M |
| Date | Value |
|---|---|
| March 31, 2019 | 30.77M |
| December 31, 2018 | 30.89M |
| September 30, 2018 | 32.19M |
| June 30, 2018 | 35.02M |
| March 31, 2018 | 33.01M |
| December 31, 2017 | 32.87M |
| September 30, 2017 | 27.78M |
| June 30, 2017 | 25.33M |
| March 31, 2017 | 25.05M |
| December 31, 2016 | 24.87M |
| September 30, 2016 | 23.90M |
| June 30, 2016 | 21.62M |
| March 31, 2016 | 22.41M |
| December 31, 2015 | 23.20M |
| September 30, 2015 | 32.08M |
| December 31, 2014 | 18.53M |
| September 30, 2014 | 14.90M |
| June 30, 2014 | 5.35M |
| March 31, 2014 | 4.65M |
| December 31, 2013 | 5.212M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
21.58M
Minimum
Sep 2022
58.68M
Maximum
Dec 2023
40.98M
Average
42.89M
Median
Total Liabilities (Quarterly) Benchmarks
| Crinetics Pharmaceuticals Inc | 103.22M |
| Pyxis Oncology Inc | 36.06M |
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 9.827M |
| iBio Inc | 25.29M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 543.03M |
| Shareholders Equity (Quarterly) | 491.89M |